Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Bupropion sustained release versus paroxetine for the treatment of depression in the elderly
K. L. Weihs
, E. C. Settle
, S. R. Batey
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bupropion sustained release versus paroxetine for the treatment of depression in the elderly'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Sustained Release
100%
Paroxetine
100%
Bupropion
100%
Major Depression
33%
Disease
16%
Adverse Event
16%
Headache
16%
Side Effect
16%
Nausea
16%
Anorexia
16%
Dizziness
16%
Diarrhea
16%
Emotional Disorder
16%
Antidepressant
16%
Somnolence
16%
Constipation
16%
DSM-IV
16%
Selective Serotonin Reuptake Inhibitor
16%
Xerostomia
16%
Neuroscience
Treatment of Depression
100%
Bupropion
100%
Paroxetine
100%
Major Depressive Disorder
33%
Anorexia
16%
Antidepressant
16%
Hamilton Rating Scale for Depression
16%
Headache
16%
Emotional Disorder
16%
Somnolence
16%
Selective Serotonin Reuptake Inhibitor
16%
Psychology
Rating Scale
100%
Anorexia
50%
Body Weight
50%
Major Depression
50%
Depression
50%
Keyphrases
Depression in Elderly
100%
Bupropion Sustained Release
100%
Monitoring Adverse Events
16%